Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA||- / 1||- / OT|
Administered by: Unknown Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Oestrone
Diagnostic Lab Data:
CDC 'Split Type': ITMODERNATX, INC.MOD20213
Write-up: ; This case was received via Regulatory Authority (Reference number: IT-MINISAL02-788670) on 24-Sep-2021 and was forwarded to Moderna on 24-Sep-2021. This regulatory authority case was reported by a physician and describes the occurrence of TACHYCARDIA in a 19-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The patient''s past medical history included Oestrone. On 13-Sep-2021, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 14-Sep-2021, the patient experienced TACHYCARDIA (seriousness criterion medically significant). On 14-Sep-2021, TACHYCARDIA had resolved. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by reporter. Treatment information was not provided Patient was suspected TPSV Tachycardia the day after the administration of modern a vaccine. Patient was admitted to the emergency room, symptoms in remission . Company comment:: This case concerns a 19 year old female patient with no relevant medical history, who experienced the unexpected event of tachycardia. The event occurred approximately1 day after the first dose of the Moderna COVID-19 vaccine. The rechallenge was unknown. The benefit-risk relationship of the Moderna COVID-19 vaccine is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 24-Sep-2021: Translation received on 29-Sep-2021 as live follow up and updated with event verbatim and Reporter''s comments; Sender''s Comments: This case concerns a 19 year old female patient with no relevant medical history, who experienced the unexpected event of tachycardia. The event occurred approximately1 day after the first dose of the Moderna COVID-19 vaccine. The rechallenge was unknown. The benefit-risk relationship of the Moderna COVID-19 vaccine is not affected by this report.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166